Detalhe da pesquisa
1.
The New Combination Docetaxel, Prednisone and Curcumin in Patients with Castration-Resistant Prostate Cancer: A Pilot Phase II Study.
Oncology
; 90(2): 69-78, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26771576
2.
Everolimus in Metastatic Breast Cancer: Clinical Experience as a Late Treatment Line.
Oncology
; 89(6): 319-31, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26457979
3.
Does regional lymph node irradiation improve the outcome of N0 and pN0 breast cancer?
Cancer Invest
; 28(2): 195-200, 2010 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-19968496
4.
Weight change during chemotherapy changes the prognosis in non metastatic breast cancer for the worse.
BMC Cancer
; 10: 648, 2010 Nov 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-21108799
5.
Long-term significance (15 years) of pathological complete response after dose-dense neoadjuvant chemotherapy in breast cancer.
Breast J
; 19(4): 448-50, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23750595
6.
Temozolomide and unusual indications: review of literature.
Cancer Treat Rev
; 39(2): 125-35, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-22818211
7.
[Poor prognostic value of weight change during chemotherapy in non-metastatic breast cancer patients: causes, mechanisms involved and preventive strategies]. / Valeur péjorative des variations de poids en cours de chimiothérapie dans le cancer du sein non métastatique : causes, mécanismes impliqués et stratégies préventives.
Bull Cancer
; 100(9): 865-70, 2013 Sep.
Artigo
em Francês
| MEDLINE | ID: mdl-24045219
8.
Phase I dose escalation trial of docetaxel plus curcumin in patients with advanced and metastatic breast cancer.
Cancer Biol Ther
; 9(1): 8-14, 2010 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19901561